Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Capital Reinvestment Ratio
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥44.34 Million) in capital expenditures (CN¥9.15 Million). See 605199 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hainan Huluwa Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Hainan Huluwa Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check how aggressively does Hainan Huluwa Pharmaceutical Group Co Lt reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025. For live market cap and broader valuation context, see market value of Hainan Huluwa Pharmaceutical Group Co Lt.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥136.85 Million | CN¥83.67 Million | ▼ -96.5% |
| 2023 | 17.32x | CN¥28.25 Million | CN¥489.20 Million | ▲ +953.6% |
| 2022 | 1.64x | CN¥238.71 Million | CN¥392.32 Million | ▲ +22.4% |
| 2021 | 1.34x | CN¥102.48 Million | CN¥137.62 Million | ▼ -92.5% |
| 2020 | 18.01x | CN¥3.30 Million | CN¥59.42 Million | ▲ +4355.8% |
| 2019 | 0.40x | CN¥144.51 Million | CN¥58.40 Million | ▼ -82.4% |
| 2018 | 2.29x | CN¥31.80 Million | CN¥72.82 Million | ▲ +30.7% |
| 2017 | 1.75x | CN¥89.96 Million | CN¥157.58 Million | ▲ +177.6% |
| 2016 | 0.63x | CN¥64.96 Million | CN¥40.99 Million | — |